International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
International Journal of Celiac Disease. 2014, 2(1), 24-26
DOI: 10.12691/ijcd-2-1-7
Open AccessEditorial

The Genetic Variability of Wheat Can Ensure Safe Products for Celiac Disease Patients?

Miguel Ribeiro1, 2, Patrícia Poeta3, 4 and Gilberto Igrejas1, 2,

1Institute for Biotechnology and Bioengineering/Center of Genomics and Biotechnology, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal

2Department of Genetics and Biotechnology, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal

3Center for Animal Science and Veterinary, Vila Real, Portugal

4Department of Veterinary Science, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal

Pub. Date: February 09, 2014

Cite this paper:
Miguel Ribeiro, Patrícia Poeta and Gilberto Igrejas. The Genetic Variability of Wheat Can Ensure Safe Products for Celiac Disease Patients?. International Journal of Celiac Disease. 2014; 2(1):24-26. doi: 10.12691/ijcd-2-1-7

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  USDA, 2013.
[2]  Payne, P.I., Holt, L.M., Lawrence, G.J., Law, C.N., “The genetics of gliadin and glutenin, the major storage proteins of the wheat endosperm”, Plant Foods Hum. Nutr., 31. 229-241. 1982.
[3]  Zuidmeer, L., Goldhahn, K., Rona, R.J., Gislason, D., Madsen, C., Summers, C., Sodergren, E., Dahlstrom, J., Lindner, T., Sigurdardottir, S.T., McBride, D., Keil, T., “The prevalence of plant food allergies: a systematic review”, J. Allergy Clin. Immunol., 121(5):1210-1218.e4. May 2008.
[4]  Comino, I., Real, A., de Lorenzo, L., Cornell, H., López-Casado, M.A., Barro, F., Lorite, P., Torres, M.I., Cebolla, A., Sousa, C., “Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease”, Gut, 60(7). 915-922. Jul 2011.
[5]  Abadie, V., Sollid, L.M., Barreiro, L.B., Jabri, B., “Integration of genetic and immunological insights into a model of celiac disease pathogenesis”, Annu. Rev. Immunol., 29. 493-525. 2011.
[6]  Sapone, A., Lammers, K.M., Casolaro, V., Cammarota, M., Giuliano, M.T., De Rosa, M., Stefanile, R., Mazzarella, G., Tolone, C., Russo, M.I., “Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity”, BMC Med., 9. 23. Mar 2011.
[7]  Gilissen, L.J.W.J., van der Meer, I.M., Smulders, M.J.M., “Reducing the incidence of allergy and intolerance to cereals”, Journal of Cereal Science, 2014.
[8]  Wieser, H., Relation between gliadin structure and coeliac toxicity. Acta Paediatr Suppl., 412. 3-9. May 1996.
[9]  Anderson, R.P., Degano, P., Godkin, A.J., Jewell, D.P., Hill, A.V.S., “In vivo antigen challenge in celiac disease identifies a single transglutaminase modified peptide as the dominant α-gliadin T-cell epitope”, Nat Med, 6(3). 337-342. Mar 2000.
[10]  Arentz-Hansen, H., Mcadam, S.N., Molberg, O., Kristiansen, C., Sollid, L.M., “Production of a panel of recombinant gliadins for the characterization of T cell reactivity in coeliac disease”, Gut, 46(1). 46-51. Jan 2000.
[11]  Arentz-Hansen, H., Mcadam, S.N., Molberg, Ø., Fleckenstein, B., Lundin, K.E.A., Jorgensen, T.J.D., Jung, G., Roepstor V.P., Sollid, L.M., “Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues”, Gastroenterology, 123(3). 803-809. Sep 2002
[12]  Camarca, A., Anderson, R.P., Mamone, G., Fierro, O., Facchiano, A., Costantini, S., Zanzi, D., Sidney, J., Auricchio, S., Sette, A., Troncone, R., Gianfrani, C., “Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease”, J Immunol., 182(7). 4158-4166. Apr 2009.
[13]  Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Raia, V., Auricchio, S., Picard, J., Osman, M., Quaratino, S., Londei, M., “Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease”, Lancet, 362(9377). 30-37. Jul 2003.
[14]  Tonutti, E, Bizzaro, N., “Diagnosis and classification of celiac disease and gluten sensitivity”, Autoimmun Rev., 2014 Jan 15. pii: S1568-9972(14)00055-X. 2014.
[15]  De Ritis, G., Auricchio, G., Jones, H.H., Lew, E.J.L., Bernardin, J. E., Kasarda, D.D., “In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in coeliac disease”, Gastroenterology, 94(1). 41-49. Jan 1988.
[16]  Camarca, A., Anderson, R.P., Mamone, G., Fierro, O., Faccchiano, A., Costantini, S., Zanzi, D., Sidney, J., Aurichchio, S., Sette, A., Troncone, R., Gianfrani, C., “Intestinal T cell responses to gluten peptides are largely heterogenous: implications for a peptide-based therapy in celiac disease”, J Immunol, 182(7). 4158-4166. Apr 2009.
[17]  Ensari, A., Marsh, M.N., Moriarty, K.J., Moore, C.M., Fido, R.J., Tatham, A.S., “Studies in vivo of omega-gliadins in gluten sensitivity (coeliac sprue disease)”, Clin Sci (Lond), 95(4). 419-424. Oct 1998.
[18]  Tye-Din, J.A., Stewart, J.A., Dromey, J.A., Beissbarth, T., van Heel, D.A., Tatham, A., Henderson, K., Mannering, S.I., Gianfrani, C., Jewell, D.P., Hill, A.V.S., McCluskey, J., Rossjohn, J., Anderson, R.P., “Design of peptide-based immunotherapy and diagnostics for celiac disease based upon comprehensive, quantitative mapping of T-cell epitopes in gluten”, Sci Trans Med, 2(41). 41ra51. Jul 2010.
[19]  Marsh, M.N., “Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity “Celiac Sprue””, Gastroenterology, 102(1). 330-354. Jan 1992.
[20]  Maruyama, N., Ichise, K., Katsube, T., Kishimoto, T., Kawase, S., Matsumura, Y., Takeuchi, Y., Sawada, T., Utsumi, S., “Identification of major wheat allergens by means of the Escherichia coli expression system”, Eur. J. Biochem., 255(3). 739-745. Aug 1998.
[21]  Shan, L., Qiao, S.W-, Arentz-Hansen, H., Molberg, Ø., Gray, G.M., Sollid, L.M., Khosla, C., “Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for Celiac Sprue”, J. Proteome Res., 4(5). 1732-1741. Sep-Oct 2005.
[22]  Rubio-Tapia, A., Hill, I.D., Kelly, C.P., Calderwood, A.H., Murray, J.A., “ACG clinical guidelines: diagnosis and management of celiac disease”, Am J Gastroenterol., 108(5). 656-676. May 2013.
[23]  Kupper, C., “Dietary guidelines and implementation for celiac disease”, Gastroenterology, 128(4 Suppl 1). S121-127. Apr 2005.
[24]  Pelkowski, T.D., Viera, A.J., “Celiac disease: diagnosis and management”, Am Fam Physician., 15, 89(2). 99-105. Jan 2014.
[25]  Pyle, G.G., Paaso, B., Anderson, B.E., Allen, D.D., Marti, T., Li, Q., Siegel, M., Khosla, C., Gray, G.M.,“Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue”, Clin Gastroenterol Hepatol., 3(7). 687-694. Jul 2005.
[26]  Bethune, M.T., Khosla, C., “Oral enzyme therapy for celiac sprue”, Methods enzymol, 502. 241-271. 2012.
[27]  Arentz-Hansen, H., Körner, R., Molberg, Ø., Quarsten, H., Vader, W., Kooy, Y.M., Lundin, K.E., Koning, F., Roepstorff, P., Sollid, L.M., McAdam, S.N.,“The Intestinal T Cell Response to α-Gliadin in Adult Celiac Disease Is Focused on a Single Deamidated Glutamine Targeted by Tissue Transglutaminase”, J Exp Med, 191(4). 603-612. Feb 2000.
[28]  Paterson, B.M., Lammers, K.M., Arrieta, M.C., Fasano, A., Meddings, J.B., “The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study”. Aliment Pharmacol Ther, 26(5). 757-766. Sep 2007.
[29]  Rosell, C.M., Barro, F., Sousa, C., Mena, M.C., “Cereals for developing gluten-free products and analytical tools for gluten detection”, Journal of Cereal Science.
[30]  Molberg, Ø., Uhlen, A.K., Jensen, T., Flæte, N. S., Fleckenstein, B., Arentz–Hansen, H., Raki, M., Lundin, K.E.A., Sollid, L.M., “Mapping of gluten T-cell epitopes in the bread wheat ancestors: Implications for celiac disease”, Gastroenterology, 128(2). 393-401. Feb 2005.
[31]  Salentijn, E.M.J., Goryunova, S., Bas, N., Van Der Meer, I.M., Van Den Broeck, H.C., Bastien, T., Gilissen, L.J.W.J., Smulders, M.J.M., “Tetraploid and hexaploid wheat varieties reveal large differences in expression of alpha-gliadins from homoeologous Gli-2 loci”, BMC Genomics, 10:48. Jan 2009.
[32]  Van Den Broeck, H.C., De Jong, H.C., Salentijn, E.M.J., Dekking, L., Bosch, D., Hamer R.J., Gilissen, L.J.W.J., Van Der Meer, I.M., Smulders, M.J.M., “Presence of celiac disease epitopes in modern and old hexaploid wheat varieties: wheat breeding may have contributed to increased prevalence of celiac disease”, Theor. Appl. Genet., 121(8). 1527-1539. Nov 2010.
[33]  Lamacchia, C., Camarca, A., Picascia, S., Di Luccia, A., Gianfrani, C., “Cereal-Based Gluten-Free Food: How to Reconcile Nutritional and Technological Properties of Wheat Proteins with Safety for Celiac Disease Patients”, Nutrients, 6(2). 575-590. Jan 2014.